Table of Contents Table of Contents
Previous Page  134 / 464 Next Page
Information
Show Menu
Previous Page 134 / 464 Next Page
Page Background

134

SCIENTIFIC PROGRAMME

| Programme and Exhibition Guide

MONDAY 8 MAY 2017

PROFFERED PAPERS

Upper and Lower GI

10:30 - 11:30 | AUDITORIUM

Chair: C. Marijnen (The Netherlands)

Chair: D. Sebag-Montefiore (UK)

10:30 > SBRT for Primary Liver Cancer in Routine Clinical Practice: A

Patterns-of-Care and Outcome Analysis

T. Brunner (Germany), N. Andratschke, S. Gerum, N. Abbasi-Senger,

M. Duma, O. Blanck, V. Lewitzki, C. Ostheimer, F. Momm, S. Wachter,

H. Alheit, M. Guckenberger, E. Gkika

OC-0424

10:40 > Clinical experience with stereotactic MR-guided adaptive radiation

therapy for pancreatic tumors

A. Bruynzeel (The Netherlands), F. Lagerwaard, O. Bohoudi, S. Tetar,

N. Haasbeek, S.S. Oei, B. Slotman, M. Meijerink, S. Senan, M. Palacios

OC-0425

10:50 > Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy

dose on survival

A.G. Morganti (Italy), M. Falconi, G.C. Mattiucci, A. Arcelli, F. Bertini,

A. Farioli, A. Guido, M.C. Di Marco, L. Fuccio, S. Alfieri, F.A. Calvo,

B.W. Maidment 3rd, R.C. Miller, M. Reni, G. Macchia, F. Deodato,

S. Cilla, G. Di Gioia, F. Cellini, V. Valentini

OC-0426

11:00 > Prediction models in rectal cancer: an update of a pooled analysis of

3770 randomized patients

V. Valentini, C. Masciocchi, J. Van Soest, G. Chiloiro, E. Meldolesi,

M. Gambacorta (Italy), J. Gerard, S. Ngan, J. Bosset, A. Sainato,

A. Damiani, N. Dinapoli, P. Lambin, A. Dekker, C. Roedel

OC-0427

11:10 > Surgical time to increase pCR in rectal cancer: pooled set of 3078

patients from 7 randomized trials

G. Chiloiro (Italy), C. Masciocchi, J. Van Soest, E. Meldolesi,

M. Gambacorta, J. Bosset, J. Doyen, J. Gerard, S. Ngan, C. Roedel,

F. Cellini, A. Damiani, N. Dinapoli, P. Lambin, A. Dekker, V. Valentini

OC-0428

11:20 > Neoadjuvant chemoradiotherapy or 5x5 Gy followed by chemotherapy

in rectal cancer: the RAPIDO trial

C. Marijnen (The Netherlands), For the cooperative group of the

RAPIDO trial

OC-0429